CJ Bioscience, Inc. (KOSDAQ:311690)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,360
-90 (-0.79%)
Last updated: Mar 25, 2025

CJ Bioscience Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Operating Revenue
3,4675,5754,0754,3635,312
Upgrade
Other Revenue
--0---
Upgrade
Revenue
3,4675,5754,0754,3635,312
Upgrade
Revenue Growth (YoY)
-37.82%36.82%-6.61%-17.86%11.04%
Upgrade
Cost of Revenue
3,1823,8022,7632,7213,072
Upgrade
Gross Profit
284.831,7731,3111,6422,240
Upgrade
Selling, General & Admin
9,6689,37112,9705,9345,375
Upgrade
Research & Development
23,16722,82319,1864,8524,984
Upgrade
Other Operating Expenses
221.72203.41111.5977.1317.09
Upgrade
Operating Expenses
34,52633,82934,54511,75010,753
Upgrade
Operating Income
-34,241-32,057-33,233-10,108-8,513
Upgrade
Interest Expense
-587.41-922.05-2,763-4,968-1,622
Upgrade
Interest & Investment Income
1,9131,3671,331410.15337.88
Upgrade
Earnings From Equity Investments
-75.66---
Upgrade
Currency Exchange Gain (Loss)
-68.27-39.3912.642.910.69
Upgrade
Other Non Operating Income (Expenses)
134.8419.86129.82-2,4851,124
Upgrade
EBT Excluding Unusual Items
-32,849-31,555-34,523-17,148-8,673
Upgrade
Gain (Loss) on Sale of Assets
10.898,642-390.710.43-89.96
Upgrade
Asset Writedown
----170.67-
Upgrade
Other Unusual Items
----1,964-
Upgrade
Pretax Income
-32,838-22,913-34,913-19,272-8,763
Upgrade
Net Income
-32,838-22,913-34,913-19,272-8,763
Upgrade
Net Income to Common
-32,838-22,913-34,913-19,272-8,763
Upgrade
Shares Outstanding (Basic)
97644
Upgrade
Shares Outstanding (Diluted)
97644
Upgrade
Shares Change (YoY)
30.93%20.50%38.23%10.14%16.93%
Upgrade
EPS (Basic)
-3541.00-3235.00-5940.02-4532.31-2269.60
Upgrade
EPS (Diluted)
-3541.00-3235.00-5940.02-4533.00-2270.00
Upgrade
Free Cash Flow
-28,138-29,823-25,108-9,390-19,997
Upgrade
Free Cash Flow Per Share
-3034.18-4210.56-4271.74-2208.24-5179.37
Upgrade
Gross Margin
8.22%31.80%32.19%37.62%42.17%
Upgrade
Operating Margin
-987.76%-575.00%-815.61%-231.68%-160.28%
Upgrade
Profit Margin
-947.28%-410.99%-856.84%-441.72%-164.97%
Upgrade
Free Cash Flow Margin
-811.70%-534.93%-616.19%-215.22%-376.48%
Upgrade
EBITDA
-29,920-26,911-29,333-8,546-7,462
Upgrade
EBITDA Margin
----195.88%-140.49%
Upgrade
D&A For EBITDA
4,3215,1463,9001,5621,051
Upgrade
EBIT
-34,241-32,057-33,233-10,108-8,513
Upgrade
EBIT Margin
----231.67%-160.28%
Upgrade
Advertising Expenses
123.79160.85131.3958.02979.43
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.